Literature DB >> 16218991

Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT1 receptor.

G V Nikiforovich1, B Mihalik, K J Catt, G R Marshall.   

Abstract

A possible molecular mechanism for the constitutive activity of mutants of the angiotensin type 1 receptor (AT1) at position 111 was suggested by molecular modeling. This involves a cascade of conformational changes in spatial positions of side chains along transmembrane helix (TM3) from L112 to Y113 to F117, which in turn, results in conformational changes in TM4 (residues I152 and M155) leading to the movement of TM4 as a whole. The mechanism is consistent with the available data of site-directed mutagenesis, as well as with correct predictions of constitutive activity of mutants L112F and L112C. It was also predicted that the double mutant N111G/L112A might possess basal constitutive activity comparable with that of the N111G mutant, whereas the double mutants N111G/Y113A, N111G/F117A, and N111G/I152A would have lower levels of basal activity. Experimental studies of the above double mutants showed significant constitutive activity of N111G/L112A and N111G/F117A. The basal activity of N111G/I152A was higher than expected, and that of N111G/Y113A was not determined due to poor expression of the mutant. The proposed mechanism of constitutive activity of the AT(1) receptor reveals a novel nonsimplistic view on the general problem of constitutive activity, and clearly demonstrates the inherent complexity of the process of G protein-coupled receptor (GPCR) activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16218991     DOI: 10.1111/j.1399-3011.2005.00293.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  7 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor.

Authors:  Gregory V Nikiforovich; Garland R Marshall; Thomas J Baranski
Journal:  Proteins       Date:  2010-11-30

3.  Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor.

Authors:  Jérôme Cabana; Brian Holleran; Marie-Ève Beaulieu; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

4.  Complement factor 5a receptor chimeras reveal the importance of lipid-facing residues in transport competence.

Authors:  Jeffery M Klco; Saurabh Sen; Jakob L Hansen; Christina Lyngsø; Gregory V Nikiforovich; Soren P Sheikh; Thomas J Baranski
Journal:  FEBS J       Date:  2009-05       Impact factor: 5.542

5.  Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex.

Authors:  Leo T O Lee; Stephanie Y L Ng; Jessica Y S Chu; Revathi Sekar; Kaleeckal G Harikumar; Laurence J Miller; Billy K C Chow
Journal:  FASEB J       Date:  2014-03-05       Impact factor: 5.191

6.  Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.

Authors:  Gregory V Nikiforovich; Thomas J Baranski
Journal:  Biochem Biophys Res Commun       Date:  2009-09-30       Impact factor: 3.575

7.  Long range effect of mutations on specific conformational changes in the extracellular loop 2 of angiotensin II type 1 receptor.

Authors:  Hamiyet Unal; Rajaganapathi Jagannathan; Anushree Bhatnagar; Kalyan Tirupula; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.